NEM
Commercial- Indications
- Joint pain, Joint stiffness, Osteoarthritis
Company intelligence / Profile preview
ESM Technologies commercializes branded wellness ingredients derived primarily from eggshell and eggshell membrane using patented chemical-free processes. Their NEM® product has received industry innovation awards for joint health. The company supplies both human and pet supplement markets with research-supported ingredients that are widely used in finished consumer products globally.
No clinical trial results are published by the company itself; however, their branded ingredients such as NEM® have been studied in peer-reviewed settings for efficacy in joint pain reduction.
Pipeline breadth and specific clinical data not disclosed; all major products appear to be commercially available.
The company operates under NSF GMP certification.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ESM Technologies.